Terry Sweeney

Terry Sweeney has extensive work experience in the pharmaceutical industry. From 1994 to 2001, they worked as a Sr. Scientist at Genentech. In 2001, they joined Nektar Therapeutics as a Sr. Director of Toxicology. Terry'sroles at Nektar Therapeutics included Executive Director and Vice President of Safety Assessment, starting in 2014 and 2018 respectively.

Terry Sweeney's education history includes a Ph.D in Physiology and Biophysics from the West Virginia University School of Medicine. The dates of enrollment and completion for this degree are unknown. Additionally, Terry Sweeney has experience as a Postdoctoral Fellow in Respiratory Biology at the Harvard T.H. Chan School of Public Health, but again, the specific time frame is not provided.